175 related articles for article (PubMed ID: 36381011)
1. Prospective Analysis of Muscle Adiposity in Children With X-linked Hypophosphatemic Rickets vs Control Children.
Nguyen-Khac V; Bonnet-Lebrun A; Linglart A; de Tienda M; Berkenou J; Mannes I; Adamsbaum C; Wicart P; Skalli W
J Endocr Soc; 2022 Oct; 6(12):bvac135. PubMed ID: 36381011
[TBL] [Abstract][Full Text] [Related]
2. MRI quantitative muscle characterization in children with X-linked hypophosphatemia.
de Tienda M; Bonnet-Lebrun A; Mannes I; Nguyen-Khac V; Ouchrif Y; Assi A; Massaad A; Linglart A; Adamsbaum C; Skalli W; Wicart P
Orthop Traumatol Surg Res; 2024 May; 110(3):103713. PubMed ID: 37863188
[TBL] [Abstract][Full Text] [Related]
3. Changes in adipose bone marrow and bone morphology in X-linked hypophosphatemic rickets.
Nguyen-Khac V; Bonnet-Lebrun A; Skalli W; Adamsbaum C; Linglart A; Wicart P
Orthop Traumatol Surg Res; 2023 May; 109(3):103529. PubMed ID: 36565743
[TBL] [Abstract][Full Text] [Related]
4. Effects of post-fracture non-weight-bearing immobilization on muscle atrophy, intramuscular and intermuscular adipose tissues in the thigh and calf.
Yoshiko A; Yamauchi K; Kato T; Ishida K; Koike T; Oshida Y; Akima H
Skeletal Radiol; 2018 Nov; 47(11):1541-1549. PubMed ID: 29948037
[TBL] [Abstract][Full Text] [Related]
5. The muscle-bone relationship in X-linked hypophosphatemic rickets.
Veilleux LN; Cheung MS; Glorieux FH; Rauch F
J Clin Endocrinol Metab; 2013 May; 98(5):E990-5. PubMed ID: 23526465
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle size is a major predictor of intramuscular fat content regardless of age.
Akima H; Yoshiko A; Hioki M; Kanehira N; Shimaoka K; Koike T; Sakakibara H; Oshida Y
Eur J Appl Physiol; 2015 Aug; 115(8):1627-35. PubMed ID: 25757882
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
Colares Neto GP; Pereira RM; Alvarenga JC; Takayama L; Funari MF; Martin RM
Osteoporos Int; 2017 May; 28(5):1685-1692. PubMed ID: 28194480
[TBL] [Abstract][Full Text] [Related]
8. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
Živičnjak M; Schnabel D; Staude H; Even G; Marx M; Beetz R; Holder M; Billing H; Fischer DC; Rabl W; Schumacher M; Hiort O; Haffner D;
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2097-105. PubMed ID: 21994957
[TBL] [Abstract][Full Text] [Related]
9. Physical function and physical activity in adults with X-linked hypophosphatemia.
Orlando G; Bubbear J; Clarke S; Keen R; Roy M; Anilkumar A; Schini M; Walsh JS; Javaid MK; Ireland A
Osteoporos Int; 2022 Jul; 33(7):1485-1491. PubMed ID: 35122145
[TBL] [Abstract][Full Text] [Related]
10. Automatic muscle and fat segmentation in the thigh from T1-Weighted MRI.
Orgiu S; Lafortuna CL; Rastelli F; Cadioli M; Falini A; Rizzo G
J Magn Reson Imaging; 2016 Mar; 43(3):601-10. PubMed ID: 26268693
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets.
Meyerhoff N; Haffner D; Staude H; Wühl E; Marx M; Beetz R; Querfeld U; Holder M; Billing H; Rabl W; Schröder C; Hiort O; Brämswig JH; Richter-Unruh A; Schnabel D; Živičnjak M;
Pediatr Nephrol; 2018 Mar; 33(3):447-456. PubMed ID: 29058153
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of three families with X-linked dominant hypophosphatemic rickets.
Lin X; Zhu Y; Luo J; Huang J
J Pediatr Endocrinol Metab; 2018 Jul; 31(7):789-797. PubMed ID: 29858904
[TBL] [Abstract][Full Text] [Related]
13. Distribution of subcutaneous and intermuscular fatty tissue of the mid-thigh measured by MRI-A putative indicator of serum adiponectin level and individual factors of cardio-metabolic risk.
Hassler EM; Deutschmann H; Almer G; Renner W; Mangge H; Herrmann M; Leber S; Michenthaler M; Staszewski A; Gunzer F; Partl R; Reishofer G
PLoS One; 2021; 16(11):e0259952. PubMed ID: 34780545
[TBL] [Abstract][Full Text] [Related]
14. Real-world effectiveness of burosumab in children with X-linked hypophosphatemic rickets.
Paloian NJ; Nemeth B; Sharafinski M; Modaff P; Steiner RD
Pediatr Nephrol; 2022 Nov; 37(11):2667-2677. PubMed ID: 35211790
[TBL] [Abstract][Full Text] [Related]
15. Inter-muscular adipose tissue is associated with adipose tissue inflammation and poorer functional performance in central adiposity.
Lim JP; Chong MS; Tay L; Yang YX; Leung BP; Yeo A; Yew S; Tan CH; Lim WS
Arch Gerontol Geriatr; 2019; 81():1-7. PubMed ID: 30469093
[TBL] [Abstract][Full Text] [Related]
16. Intermuscular adipose tissue and thigh muscle area dynamics during an 18-month randomized weight loss trial.
Yaskolka Meir A; Shelef I; Schwarzfuchs D; Gepner Y; Tene L; Zelicha H; Tsaban G; Bilitzky A; Komy O; Cohen N; Bril N; Rein M; Serfaty D; Kenigsbuch S; Chassidim Y; Zeller L; Ceglarek U; Stumvoll M; Blüher M; Thiery J; Stampfer MJ; Rudich A; Shai I
J Appl Physiol (1985); 2016 Aug; 121(2):518-27. PubMed ID: 27402560
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular adipose tissue determined by T1-weighted MRI at 3T primarily reflects extramyocellular lipids.
Akima H; Hioki M; Yoshiko A; Koike T; Sakakibara H; Takahashi H; Oshida Y
Magn Reson Imaging; 2016 May; 34(4):397-403. PubMed ID: 26743430
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia.
Zhukouskaya VV; Rothenbuhler A; Colao A; Di Somma C; Kamenický P; Trabado S; Prié D; Audrain C; Barosi A; Kyheng C; Lambert AS; Linglart A
Endocr Connect; 2020 Feb; 9(2):144-153. PubMed ID: 31910157
[TBL] [Abstract][Full Text] [Related]
19. Estimating whole body intermuscular adipose tissue from single cross-sectional magnetic resonance images.
Ruan XY; Gallagher D; Harris T; Albu J; Heymsfield S; Kuznia P; Heshka S
J Appl Physiol (1985); 2007 Feb; 102(2):748-54. PubMed ID: 17053107
[TBL] [Abstract][Full Text] [Related]
20. Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.
Ward LM; Glorieux FH; Whyte MP; Munns CF; Portale AA; Högler W; Simmons JH; Gottesman GS; Padidela R; Namba N; Cheong HI; Nilsson O; Mao M; Chen A; Skrinar A; Roberts MS; Imel EA
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3241-e3253. PubMed ID: 35533340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
